| (EUR) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 143.48M | — |
| Operating expense | — | — |
| Net income | -46.65M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, EVT.F returned -46.2% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -40.2% |
| 1 year | -46.2% |
| 5 years | -92.2% |
| 10 years | -27.1% |
| All-time high | €42.51 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in EVT.F would be worth today ›No. Evotec SE has not paid a dividend in the past 12 months.
Evotec SE is part of the Healthcare sector.
Evotec SE has a market cap of 580.00M EUR, based on the latest quote.
Evotec SE is scheduled to report earnings on Nov 5, 2026.